Dr. Armini received a Ph.D. in Nuclear Physics from UCLA. His professional career began in the aerospace industry, then transitioned to using particle accelerators and nuclear reactors to manufacture semiconductor and medical devices over a career spanning 40 years.
In 1984 he founded Implant Sciences Corp. (IMSC) and served as CEO and Chief Technical Officer until retirement.  While at the company he developed and manufactured radioactive implants for the treatment of prostate and breast cancer, and developed a radioactive coronary stent for treatment of heart disease. During this time he used research reactors in the U.S., Canada, Europe, and South Africa to develop and activate the medical devices IMSC manufactured and sold.
Dr. Armini has been issued 22 U.S. patents, has spoken at many scientific conferences, and has published numerous technical papers.